Caxton Associates LP Boston Scientific Corp Transaction History

Caxton Associates LP

$3.12 Billion
Q4 2024

A detailed history of Caxton Associates LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Caxton Associates LP holds 701,105 shares of BSX stock, worth $74.6 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

701,105

Previous 700,000 0.16%

Holding current value

$74.6 Million

Previous $58.7 Million 6.75%

% of portfolio

2.01%

Previous 2.21%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$83.62 - $91.5 $92,400 - $101,107	1,105 Added 0.16%	701,105 $62.6 Million
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $51.1 Million - $58.8 Million	700,000 New	700,000 $58.7 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $1.84 Million - $5.48 Million	50,000 New	50,000 $1.94 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $2.49 Million - $3.15 Million	-75,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $2.58 Million - $3.17 Million	75,000 New	75,000 $2.87 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $762,434 - $938,683	-21,840 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $718,754 - $889,980	21,840 New	21,840 $838,000
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $206,213 - $253,720	-6,499 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $213,362 - $251,056	6,499 New	6,499 $250,000
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $1.13 Million - $1.28 Million	-44,975 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $1.11 Million - $1.34 Million	44,975	44,975 $1.12 Million

Others Institutions Holding BSX

# of Institutions

1,867

Shares Held

1.22B

Call Options Held

9.9M

Put Options Held

7.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $152B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Boston Scientific Corp Transaction History